NCT04029233
The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
Phase: N/A
Role: Lead Sponsor
Start: Oct 3, 2019
Completion: Apr 16, 2024